...
首页> 外文期刊>Drug discovery today >Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents
【24h】

Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents

机译:用特别强调抗癌剂的药物化学丙酮酸脱氢酶激酶抑制剂的研制

获取原文
获取原文并翻译 | 示例
           

摘要

Many cancer cells demonstrate a high rate of glucose consumption via glycolysis to provide intermediates for macromolecule biosynthesis. To accomplish this metabolic change, the expression of pyruvate dehydrogenase kinases (PDKs) is rapidly increased in cancer cells. Inhibition of PDKs could promote the function of mitochondria by increasing the oxidative metabolism of pyruvate, resulting in the death of cancer cells. In this review, we provide an overview of the structural information available for PDKs and their connections to known therapeutic effects. We then describe the development of small molecule PDK inhibitors in medicinal chemistry with particular emphasis as anticancer agents. Finally, directions for further development of PDK inhibitors as potential anticancer agents are discussed.
机译:许多癌细胞通过糖酵解证明了高葡萄糖消耗,以提供用于大分子生物合成的中间体。 为了实现这种代谢变化,丙酮酸脱氢酶激酶(PDK)的表达在癌细胞中迅速增加。 通过增加丙酮酸的氧化代谢来促进PDK的抑制可以促进线粒体的功能,导致癌细胞死亡。 在本次审查中,我们概述了可用于PDK的结构信息及其与已知治疗效果的关系。 然后,我们描述了药物化学中小分子PDK抑制剂的发展,特别强调抗癌剂。 最后,讨论了PDK抑制剂进一步发展的方向作为潜在的抗癌剂。

著录项

  • 来源
    《Drug discovery today》 |2015年第9期|共8页
  • 作者单位

    Univ Macau Fac Hlth Sci Drug Dev Core Macau Peoples R China;

    Univ Macau Fac Hlth Sci Drug Dev Core Macau Peoples R China;

    Univ Macau Fac Hlth Sci Drug Dev Core Macau Peoples R China;

    Univ Macau Fac Hlth Sci Drug Dev Core Macau Peoples R China;

    Univ Macau Fac Hlth Sci Drug Dev Core Macau Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号